ArticleJournal of gastrointestinal oncology2025

Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings.

Qun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.